hrs4r
Quiero donar
Firma
GARY ÁLVAREZ-BRAVO
Posición
Investigador/a Pre-doctoral – R1
Investigadores/as Pre-doctorales – R1

Projectes

Codi oficial: HZ16YWZ3K Data inicio:01/01/2023 Data fi: 31/12/2024 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER. Ajuda: 0 €

Publicacions

Muñoz-San Martín M, Gómez I, Quiroga-Varela A, Gonzalez-Del Río M, Robles Cedeño R, Álvarez G, Buxó M, Miguela A, Villar LM, Castillo-Villalba J, Casanova B, Quintana E, Ramió-Torrentà L

miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 dx.doi.org/10.1212/NXI.0000000000200069

Álvarez Bravo G, Sánchez Cirera L, Angerri Nadal M, Ramió I Torrentà L

Clinical heterogeneity in patients with myoclonus associated to COVID-19

NEUROLOGICAL SCIENCES, 2022, 43, 1587-1592 dx.doi.org/10.1007/s10072-021-05802-1

Zabalza A, Arrambide G, Otero-Romero S, Pappolla A, Tagliani P, López-Maza S, Cárdenas-Robledo S, Esperalba J, Fernández-Naval C, Martínez-Gallo M, Castillo M, Bonastre M, Resina-Salles M, Bertran J, Rodriguez-Barranco M, Carbonell-Mirabent P, Gonzalez M, Merchan M, Quiroga-Varela A, Miguela A, Gómez I, Álvarez G, Robles R, Perez Del Campo D, Queralt X, Soler MJ, Agraz I, Martinez-Valle F, Rodríguez-Acevedo B, Midaglia L, Vidal-Jordana Á, Cobo-Calvo Á, Tur C, Galan I, Castillo J, Río J, Espejo C, Comabella M, Nos C, Sastre-Garriga J, Ramió-Torrentà L, Tintoré M, Montalban X

Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?

MULTIPLE SCLEROSIS JOURNAL, 2022, 28, 1138-1145 dx.doi.org/10.1177/13524585221089540
0

Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives

Cells, 2022, 11 dx.doi.org/10.3390/cells11132058

Coll-Martinez C, Quintana E, Salavedra-Pont J, Buxó M, González-Del-Rio M, Gómez I, Muñoz-San Martín M, Villar LM, Álvarez-Bravo G, Robles-Cedeño R, Ramió-Torrentà L, Gich J

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

BRAIN AND BEHAVIOR, 2021, 11 dx.doi.org/10.1002/brb3.2405

Mestre Fusco A, Beltrán Mármol B, Álvarez Bravo G, Ferran Sureda N, Negre Busó M, Rubió Rodríguez A

PET coregistered with MRI imaging of anti-NMDAR encephalitis patient with SARS-CoV-2 infection.

Revista Espanola De Medicina Nuclear E Imagen Molecular, 2021, 41 Suppl 1 dx.doi.org/10.1016/j.remnie.2021.09.004

Álvarez Bravo G

Creutzfeldt-Jakob Disease as a Novel Cause of Wing-Beating Tremor

JAMA NEUROLOGY, 2021, 78, 249-250 dx.doi.org/10.1001/jamaneurol.2020.3899

Álvarez Bravo G, Ramió I Torrentà L

Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection

Neurologia, 2020, 35, 699-700 dx.doi.org/10.1016/j.nrl.2020.07.013
0

COVID19-associated new-onset movement disorders: a follow-up study.

JOURNAL OF NEUROLOGY, 1-7 dx.doi.org/10.1007/s00415-023-11661-x

Formulari de contacte

Conoce el IDIBGI!

menu